The GPC1-negative cases possessed both wild-type KRAS and mutant KRAS. The GPC1-negative cases with mutant KRAS were all intestinal-type IPMN. This evidence concerns the gene GPC1 and pancreatic intraductal papillary-mucinous neoplasm.